Cartesian Therapeutics (RNAC) Other Operating Expenses (2023 - 2025)
Cartesian Therapeutics (RNAC) posted quarterly Other Operating Expenses of $56.7 million for Q4 2025, up 648.12% year-over-year from $7.6 million in Q4 2024, and up 648.12% quarter-over-quarter from $7.6 million in Q4 2024.
Cartesian Therapeutics (RNAC) Other Operating Expenses (2023 - 2025) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Other Operating Expenses for 3 consecutive years, with $56.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Operating Expenses rose 648.12% year-over-year to $56.7 million; the TTM figure through Mar 2026 stood at $56.7 million (up 648.12% YoY), while the FY2025 annual figure was $56.7 million, up 648.12% from the prior year.
- Other Operating Expenses grew to $56.7 million in Q4 2025 per RNAC's latest filing, from $7.6 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $56.7 million in Q4 2025 and bottomed at $710000.0 in Q4 2023.
- Historically, Other Operating Expenses has averaged $21.7 million across 3 years, with a median of $7.6 million in 2024.
- Annual changes were most pronounced in 2024 — Other Operating Expenses soared 967.46% — and 2025, when it surged 648.12%.
- Cartesian Therapeutics' Other Operating Expenses stood at $710000.0 in 2023, then jumped by 967.46% to $7.6 million in 2024, then soared by 648.12% to $56.7 million in 2025.
- Business Quant data shows RNAC's Other Operating Expenses at $56.7 million in Q4 2025, $7.6 million in Q4 2024, and $710000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56.70 Mn |
| Dec 31, 2024 | 7.58 Mn |
| Dec 31, 2023 | 710,000.00 |